Specifically, we demonstrated that SORBS1 knockdown induced EMT, FLPs formation, migration, and invasion, and that these effects were abrogated by treatment of the same cancer cells with a small-molecule JNK inhibitor. The gene discussed is SORBS1; the disease is cancer.